ProCE Banner Activity

Inpatient and Outpatient Management of Immune-Related Adverse Events for Pharmacists

Clinical Thought

Alexa Basilio, PharmD, BCOP, and Jordan McPherson, PharmD, MS, BCOP, discuss when to admit a patient with an irAE to the hospital and how inpatient and outpatient pharmacists can coordinate care.

Released: July 12, 2023

Share

Faculty

Alexa Basilio

Alexa Basilio, PharmD, BCOP

Clinical Oncology Pharmacy Specialist 
Emory Healthcare, Winship Cancer Institute
Atlanta, Georgia 

Jordan McPherson

Jordan McPherson, PharmD, MS, BCOP

Interim Clinical Manager
Huntsman Cancer Institute
Oncology Clinical Pharmacist
Melanoma and Non-Melanoma Skin Cancers
Adjunct Associate Professor
University of Utah College of Pharmacy
Salt Lake City, Utah

Provided by

Provided by ProCE, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC

Faculty Disclosure

Primary Author

Alexa Basilio, PharmD, BCOP

Clinical Oncology Pharmacy Specialist 
Emory Healthcare, Winship Cancer Institute
Atlanta, Georgia 

Alexa Basilio, PharmD, BCOP, has no relevant financial relationships to disclose.

Jordan McPherson, PharmD, MS, BCOP

Interim Clinical Manager
Huntsman Cancer Institute
Oncology Clinical Pharmacist
Melanoma and Non-Melanoma Skin Cancers
Adjunct Associate Professor
University of Utah College of Pharmacy
Salt Lake City, Utah

Jordan McPherson, PharmD, MS, BCOP: researcher: Hitachi, Ltd.